Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-12-000057
Filing Date
2012-11-14
Accepted
2012-11-14 16:02:39
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-093012.htm 10-Q 605550
2 CEO CERTIFICATION ex_31-1.htm EX-31.1 16177
3 CFO CERTIFICATION ex_31-2.htm EX-31.2 16258
4 CEO CERTIFICATION ex_32-1.htm EX-32.1 6005
5 CFO CERTIFICATION ex_32-2.htm EX-32.2 6201
  Complete submission text file 0000318306-12-000057.txt   2855521

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE REPORT accp-20120930.xml EX-101.INS 345986
7 XBRL TAXONOMY SCHEMA accp-20120930.xsd EX-101.SCH 17433
8 XBRL TAXONOMY CALCULATION LINKBASE accp-20120930_cal.xml EX-101.CAL 42519
9 XBRL TAXONOMY DEFINITION LINKBASE accp-20120930_def.xml EX-101.DEF 65723
10 XBRL TAXONOMY LABEL LINKBASE accp-20120930_lab.xml EX-101.LAB 257175
11 XBRL TAXONOMY PRESENTATION LINKBASE accp-20120930_pre.xml EX-101.PRE 162963
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 121204333
SIC: 2834 Pharmaceutical Preparations